1 BIOPAT. Biopatologia Molecular. Grup Assistència. Barcelona. 2 Histopat laboratoris, Barcelona. 3 Departamento de Estadística de la Universidad de Barcelona. Barcelona. 4 Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York.
Montse Verdú1, Anna Colomer2, Ruth Román2, Nadina Erill2, Miquel Calvo3, Abelardo Moreno1, Carlos Cordon-Cardó4, Xavier Puig 1,2.
1HISTOPAT Laboratoris, Barcelona. 2BIOPAT, Biopatologia Molecular, Barcelona. 3Departament d’Estadística de la Universitat de Barcelona, Barcelona y 4Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA.
The HER2/neu proto-oncogen is frequently amplified in breast cancer, and serves as a […]
Nadina Erill1, Anna Colomer1, Miquel Calvo2, August Vidal3, Ruth Román1, Montse Verdú3, Carlos Cordón-Cardó4, Xavier Puig 1,3.
1BIOPAT, Grup Assistència, 2Statistics Department, Universitat de Barcelona, 3HISTOPAT Laboratoris, Barcelona, and 4Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York.
Chromosome 18q allelic loss has been reported to have prognostic significance in stage II colorectal carcinoma. We have […]
Anna Colomer1, Nadina Erill1, August Vidal2, Miquel Calvo3, Ruth Román1, Montse Verdú2, Carlos Cordon-Cardo4, Xavier Puig 1,2.
1BIOPAT, Grup Assistència, Barcelona; 2HISTOPAT Laboratoris, Barcelona; 3Statistics Department of the Universitat de Barcelona, Barcelona and 4Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York.
High-frequency microsatellite instability has been reported to be […]
M. J. Donovan, A. Kotsianti, A. Colomer, M. Verdú, M. Clayton, H. Pang, S. Hamann, C. Cordón-Cardó, X. Puig.
Background: The association of EGFR mutations with bronchoalveolar carcinoma (BAC) / non-small cell lung cancer (NSCLC) and the therapeutic and prognostic variability reported for lung cancer has reinforced the need for more accurate NSCLC sub-classification. The present […]